Surface Oncology, Inc.

NasdaqCM:SURF 주식 보고서

시가총액: US$65.1m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Surface Oncology 관리

관리 기준 확인 3/4

Surface Oncology CEO는 Rob Ross, Apr2021 에 임명되었습니다 의 임기는 2.42 년입니다. 총 연간 보상은 $ 1.92M, 29.5% 로 구성됩니다. 29.5% 급여 및 70.5% 보너스(회사 주식 및 옵션 포함). 는 $ 89.02K 가치에 해당하는 회사 주식의 0.14% 직접 소유합니다. 89.02K. 경영진과 이사회의 평균 재임 기간은 각각 2.4 년과 4.7 년입니다.

주요 정보

Rob Ross

최고 경영자

US$1.9m

총 보상

CEO 급여 비율29.5%
CEO 임기2.4yrs
CEO 소유권0.1%
경영진 평균 재임 기간2.4yrs
이사회 평균 재임 기간4.7yrs

최근 관리 업데이트

Recent updates

Forecast: Analysts Think Surface Oncology, Inc.'s (NASDAQ:SURF) Business Prospects Have Improved Drastically

Nov 07
Forecast: Analysts Think Surface Oncology, Inc.'s (NASDAQ:SURF) Business Prospects Have Improved Drastically

Analysts Just Made A Major Revision To Their Surface Oncology, Inc. (NASDAQ:SURF) Revenue Forecasts

Aug 08
Analysts Just Made A Major Revision To Their Surface Oncology, Inc. (NASDAQ:SURF) Revenue Forecasts

Surface Oncology GAAP EPS of -$0.46 misses by $0.01

Aug 03

Surface Oncology: Neither Novartis, Nor GSK Or ARKG Is Able To Stop The Decline

May 25

News Flash: Analysts Just Made A Dazzling Upgrade To Their Surface Oncology, Inc. (NASDAQ:SURF) Forecasts

May 11
News Flash: Analysts Just Made A Dazzling Upgrade To Their Surface Oncology, Inc. (NASDAQ:SURF) Forecasts

Does Surface Oncology (NASDAQ:SURF) Have A Healthy Balance Sheet?

Feb 23
Does Surface Oncology (NASDAQ:SURF) Have A Healthy Balance Sheet?

Surface Oncology: If Novartis, GlaxoSmithKline And ARK See Promise, So Do I

Jan 18

Is Surface Oncology (NASDAQ:SURF) A Risky Investment?

Nov 11
Is Surface Oncology (NASDAQ:SURF) A Risky Investment?

Surface Oncology: Staying The Course

Oct 24

Surface Oncology: A Diverse, But Early Pipeline

Jul 13

Is Surface Oncology (NASDAQ:SURF) Using Too Much Debt?

Jun 07
Is Surface Oncology (NASDAQ:SURF) Using Too Much Debt?

Surface Oncology EPS beats by $0.04, beats on revenue

May 05

Here's What Surface Oncology, Inc.'s (NASDAQ:SURF) Shareholder Ownership Structure Looks Like

Mar 15
Here's What Surface Oncology, Inc.'s (NASDAQ:SURF) Shareholder Ownership Structure Looks Like

Does Surface Oncology (NASDAQ:SURF) Have A Healthy Balance Sheet?

Feb 16
Does Surface Oncology (NASDAQ:SURF) Have A Healthy Balance Sheet?

Surface Oncology: Early Stage Cancer-Specific Company With Novel Assets

Dec 09

What Kind Of Shareholders Hold The Majority In Surface Oncology, Inc.'s (NASDAQ:SURF) Shares?

Dec 08
What Kind Of Shareholders Hold The Majority In Surface Oncology, Inc.'s (NASDAQ:SURF) Shares?

Surface Oncology shares rise 13% on Fast Track tag for SRF388

Nov 11

CEO 보상 분석

Rob Ross 의 보수는 Surface Oncology 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2023n/an/a

-US$93m

Mar 31 2023n/an/a

-US$90m

Dec 31 2022US$2mUS$568k

-US$64m

Sep 30 2022n/an/a

-US$66m

Jun 30 2022n/an/a

-US$63m

Mar 31 2022n/an/a

-US$57m

Dec 31 2021US$5mUS$506k

-US$78m

Sep 30 2021n/an/a

US$13m

Jun 30 2021n/an/a

US$17m

Mar 31 2021n/an/a

US$21m

Dec 31 2020US$1mUS$435k

US$59m

Sep 30 2020n/an/a

-US$24m

Jun 30 2020n/an/a

-US$25m

Mar 31 2020n/an/a

-US$28m

Dec 31 2019US$810kUS$400k

-US$55m

Sep 30 2019n/an/a

-US$44m

Jun 30 2019n/an/a

-US$44m

Mar 31 2019n/an/a

-US$35m

Dec 31 2018US$880kUS$361k

-US$7m

Sep 30 2018n/an/a

-US$18m

Jun 30 2018n/an/a

-US$15m

Mar 31 2018n/an/a

-US$13m

Dec 31 2017US$467kUS$329k

-US$45m

보상 대 시장: Rob 의 총 보상 ($USD 1.92M )은 US 시장( $USD 646.00K ).

보상과 수익: Rob 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Rob Ross (49 yo)

2.4yrs

테뉴어

US$1,924,455

보상

Dr. Robert W. Ross, also known as Rob, M.D., is President, Chief Executive Officer and Director at Surface Oncology, Inc since April 01, 2021. He serves as Independent Director at Xilio Therapeutics, Inc....

리더십 팀

이름위치테뉴어보상소유권
Robert Ross
President2.4yrsUS$1.92m0.14%
$ 89.0k
Alison O'Neill
Chief Medical Officer3.6yrsUS$1.06m데이터 없음
Jessica Fees
CFO & Treasurer4.8yrs데이터 없음0.17%
$ 109.1k
Chandra Adams
Deputy General Counsel & Secretaryless than a year데이터 없음0.051%
$ 33.1k
Lisa McGrath
Chief People Officerno data데이터 없음데이터 없음
Shannon Devens
Senior Vice President of Development Operations1.8yrs데이터 없음데이터 없음

2.4yrs

평균 재임 기간

52yo

평균 연령

경험이 풍부한 관리: SURF 의 관리팀은 경험 ( 2.4 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Robert Ross
President2.4yrsUS$1.92m0.14%
$ 89.0k
Charles Sigal
Independent Member of Scientific Advisory Board & Director5.6yrsUS$80.57k0.075%
$ 48.6k
David Grayzel
Independent Director9.4yrsUS$84.57k0%
$ 0
J. Goater
Director5.6yrsUS$72.57k0.21%
$ 138.3k
Alexander Rudensky
Member of Scientific Advisory Board4.7yrs데이터 없음데이터 없음
Armen Shanafelt
Independent Director8.8yrsUS$89.07k0%
$ 0
Laurie Stelzer
Independent Director5.6yrsUS$92.57k0%
$ 0
F. Hodi
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Denice Torres
Independent Chairman & Lead Independent Director2.2yrsUS$151.82k0%
$ 0
Christopher Hunter
Member of Scientific Advisory Board4.7yrs데이터 없음데이터 없음
Carla Rothlin
Member of Scientific Advisory Board4.7yrs데이터 없음데이터 없음
Arlene Sharpe
Member of Scientific Advisory Board4.7yrs데이터 없음데이터 없음

4.7yrs

평균 재임 기간

55yo

평균 연령

경험이 풍부한 이사회: SURF 의 이사회는 경험(평균 재직 기간 4.7 년)으로 간주됩니다.